CONDENSED CONSOLIDATED STATEMENTS of SHAREHOLDERS' DEFICIT (Unaudited) - USD ($)	Total	Common Stock	Additional Paid-In Capital	Noncontrolling Interest	Accumulatd Deficit [Member]	Total Deficit Member
Balance, shares at Dec. 31, 2023		76,247,370
Balance, amount at Dec. 31, 2023	$ (45,005,297)	$ 7,627	$ 181,753,261	$ (1,473,852)	$ (225,292,333)	$ (43,531,445)
Exercise of cashless warrants, shares		871,620
Exercise of cashless warrants, amount	0	$ 87	(87)	0	0	0
Exercise of common stock options, shares		148,000
Exercise of common stock options, amount	156,897	$ 15	156,882	0	0	156,897
Issuance of common shares for consulting services, shares		30,000
Issuance of common shares for consulting services, amount	43,800	$ 3	43,797	0	0	43,800
Dividend-in-kind of Novustera, Inc. common stock to shareholders	(1,361,788)	0	0	0	(1,361,788)	(1,361,788)
Stock compensation - options	986,132	0	986,132	0	0	986,132
Net loss	7,021,122	$ 0	0	(79,760)	(6,941,362)	(6,941,362)
Balance, shares at Mar. 31, 2024		77,296,990
Balance, amount at Mar. 31, 2024	(52,201,378)	$ 7,732	182,939,985	(1,553,612)	(233,595,483)	(50,647,766)
Balance, shares at Dec. 31, 2023		76,247,370
Balance, amount at Dec. 31, 2023	(45,005,297)	$ 7,627	181,753,261	(1,473,852)	(225,292,333)	(43,531,445)
Balance, shares at Sep. 30, 2024		77,400,289
Balance, amount at Sep. 30, 2024	(71,941,370)	$ 7,742	184,934,174	(1,554,740)	(255,328,546)	(70,386,630)
Balance, shares at Mar. 31, 2024		77,296,990
Balance, amount at Mar. 31, 2024	(52,201,378)	$ 7,732	182,939,985	(1,553,612)	(233,595,483)	(50,647,766)
Issuance of common shares for consulting services, shares		72,500
Issuance of common shares for consulting services, amount	99,775	$ 7	99,768	0	0	99,775
Stock compensation - options	956,816	0	956,816	0	0	956,816
Net loss	(11,107,751)	$ 0	0	14,337	(11,122,088)	(11,122,088)
Exercise of common stock warrants, shares		30,799
Exercise of common stock warrants, amount	32,339	$ 3	32,336	0	0	32,339
Balance, shares at Jun. 30, 2024		77,400,289
Balance, amount at Jun. 30, 2024	(62,220,199)	$ 7,742	184,028,905	(1,539,275)	(244,717,571)	(60,680,924)
Stock compensation - options	905,269	0	905,269	0	0	905,269
Net loss	(10,626,440)	$ 0	0	(15,465)	(10,610,975)	(10,610,975)
Balance, shares at Sep. 30, 2024		77,400,289
Balance, amount at Sep. 30, 2024	(71,941,370)	$ 7,742	184,934,174	(1,554,740)	(255,328,546)	(70,386,630)
Balance, shares at Dec. 31, 2024		77,996,079
Balance, amount at Dec. 31, 2024	(81,051,810)	$ 7,802	186,407,169	(1,561,666)	(265,905,115)	(79,490,144)
Stock compensation - options	518,624	$ 0	518,624	0	0	518,624
Common stock issued to settle accounts payable and accrued expenses, shares		2,495,770
Common stock issued to settle accounts payable and accrued expenses, amount	1,544,103	$ 244	1,543,859	0	0	1,544,103
Net loss	(6,656,039)	$ 0	0	(3,292,809)	(3,363,230)	(3,363,230)
Balance, shares at Mar. 31, 2025		80,491,849
Balance, amount at Mar. 31, 2025	(85,645,122)	$ 8,046	188,469,652	(4,854,475)	(269,268,345)	(80,790,647)
Balance, shares at Dec. 31, 2024		77,996,079
Balance, amount at Dec. 31, 2024	(81,051,810)	$ 7,802	186,407,169	(1,561,666)	(265,905,115)	(79,490,144)
Balance, shares at Sep. 30, 2025		85,976,023
Balance, amount at Sep. 30, 2025	(95,062,105)	$ 8,452	195,414,969	(14,387,150)	(276,098,376)	(80,674,955)
Balance, shares at Mar. 31, 2025		80,491,849
Balance, amount at Mar. 31, 2025	(85,645,122)	$ 8,046	188,469,652	(4,854,475)	(269,268,345)	(80,790,647)
Stock compensation - options	592,188	$ 0	592,188	0	0	592,188
Common stock issued to settle accounts payable and accrued expenses, shares		3,813,222
Common stock issued to settle accounts payable and accrued expenses, amount	2,381,457	$ 239	2,381,218	0	0	2,381,457
Net loss	(8,661,993)	$ 0	0	(6,233,465)	(2,428,528)	(2,428,528)
Balance, shares at Jun. 30, 2025		84,305,071
Balance, amount at Jun. 30, 2025	$ (91,333,470)	$ 8,285	191,443,058	(11,087,940)	(271,696,873)	(80,245,530)
Exercise of common stock options, shares	314,801	314,801
Exercise of common stock options, amount	$ 0	$ 31	(31)	0	0	0
Stock compensation - options	716,463	$ 0	716,463	0	0	716,463
Common stock issued to settle accounts payable and accrued expenses, shares		707,270
Common stock issued to settle accounts payable and accrued expenses, amount	2,044,011	$ 71	2,043,940	0	0	2,044,011
Net loss	(7,700,713)	$ 0	0	(3,299,210)	(4,401,503)	(4,401,503)
Common stock issued to settle convertible debt - related party, shares		282,881
Common stock issued to settle convertible debt - related party, amount	356,430	$ 28	356,402	0	0	356,430
Common stock issued to settle long-term debt, shares		366,000
Common stock issued to settle long-term debt, amount	855,174	$ 37	855,137	0	0	855,174
Balance, shares at Sep. 30, 2025		85,976,023
Balance, amount at Sep. 30, 2025	$ (95,062,105)	$ 8,452	$ 195,414,969	$ (14,387,150)	$ (276,098,376)	$ (80,674,955)